Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 13, 2024International Journal of Cardiology Cardiovascular Risk and PreventionOpen Access

Resveratrol reinforces the therapeutic effect of mesenchymal stem cell (MSC)-derived exosomes against renal ischemia‒reperfusion injury (RIRI)-associated fibrosis by suppressing TGF-β-induced epithelial-mesenchymal transition

View Full Paper
Ask AI
Bookmark
Share

Authors

FLFuhe LiuFoshan UniversityJXJinlong XuJiangsu UniversityFLFen LiCentral South University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e79585b6db643587706428https://doi.org/10.1016/j.ijcrp.2024.200242
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction2017 · 184 citations
  2. 2The Dying Stem Cell Hypothesis2005 · 187 citations
  3. 3Oxidant Mechanisms in Renal Injury and Disease2016 · 705 citations
  4. 4Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives2016 · 40 citations
  5. 5Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis2006 · 117 citations